The 10-day moving average for CIA crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CIA as a result. In 78 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
CIA moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +11.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CIA advanced for three days, in 205 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CIA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
CIA broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CIA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 51 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.889) is normal, around the industry mean (1.352). P/E Ratio (17.957) is within average values for comparable stocks, (20.493). Projected Growth (PEG Ratio) (1.090) is also within normal values, averaging (0.463). CIA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.047). P/S Ratio (0.718) is also within normal values, averaging (1.303).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. CIA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CIA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where MET advanced for three days, in 228 of 348 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on MET as a result. In 48 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 57%.
The Moving Average Convergence Divergence (MACD) for MET just turned positive on November 04, 2026. Looking at past instances where MET's MACD turned positive, the stock continued to rise in 32 of 52 cases over the following month. The odds of a continued upward trend are 62%.
MET moved above its 50-day moving average on October 08, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MET crossed bullishly above the 50-day moving average on October 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 156 of 283 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.
The 10-day RSI Indicator for MET moved out of overbought territory on October 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 25 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 53%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 68 cases where MET's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
MET broke above its upper Bollinger Band on October 12, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. MET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MET's P/B Ratio (2.383) is slightly higher than the industry average of (1.352). P/E Ratio (19.561) is within average values for comparable stocks, (20.493). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (0.463). Dividend Yield (0.023) settles around the average of (0.047) among similar stocks. P/S Ratio (0.824) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CIA | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 35 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 51 Fair valued | 56 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 20 | |
SMR RATING 1..100 | 100 | 99 | |
PRICE GROWTH RATING 1..100 | 62 | 19 | |
P/E GROWTH RATING 1..100 | 84 | 12 | |
SEASONALITY SCORE 1..100 | 85 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CIA's Valuation (51) in the Life Or Health Insurance industry is in the same range as MET (56). This means that CIA’s stock grew similarly to MET’s over the last 12 months.
MET's Profit vs Risk Rating (20) in the Life Or Health Insurance industry is significantly better than the same rating for CIA (100). This means that MET’s stock grew significantly faster than CIA’s over the last 12 months.
MET's SMR Rating (99) in the Life Or Health Insurance industry is in the same range as CIA (100). This means that MET’s stock grew similarly to CIA’s over the last 12 months.
MET's Price Growth Rating (19) in the Life Or Health Insurance industry is somewhat better than the same rating for CIA (62). This means that MET’s stock grew somewhat faster than CIA’s over the last 12 months.
MET's P/E Growth Rating (12) in the Life Or Health Insurance industry is significantly better than the same rating for CIA (84). This means that MET’s stock grew significantly faster than CIA’s over the last 12 months.
| CIA | MET | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 79% | 2 days ago 53% |
| Stochastic ODDS (%) | 2 days ago 71% | 2 days ago 53% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 57% |
| MACD ODDS (%) | N/A | 2 days ago 62% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 54% |
| Advances ODDS (%) | 2 days ago 78% | 2 days ago 66% |
| Declines ODDS (%) | 11 days ago 81% | 9 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 76% | 2 days ago 51% |
| Aroon ODDS (%) | 2 days ago 77% | 2 days ago 55% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CIA’s FA Score shows that 0 FA rating(s) are green while MET’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CIA’s TA Score shows that 4 TA indicator(s) are bullish while MET’s TA Score has 6 bullish TA indicator(s).
CIA (@Life/Health Insurance) experienced а +8.68% price change this week, while MET (@Life/Health Insurance) price change was +3.87% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -0.38%. For the same industry, the average monthly price growth was -1.32%, and the average quarterly price growth was -4.04%.
CIA is expected to report earnings on Mar 18, 2027.
MET is expected to report earnings on Feb 03, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, CIA has been loosely correlated with MET. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CIA jumps, then MET could also see price increases.
A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DRN | 10.88 | 0.98 | +9.90% |
| Direxion Daily Real Estate Bull 3X ETF (DRN) | |||
| KRE | 74.13 | 1.25 | +1.72% |
| State Street SPDR S&P Regional Banking ETF (KRE) | |||
| EDGX | 26.51 | 0.38 | +1.45% |
| Global X U.S. 500 Income Edge ETF (EDGX) | |||
| IBMR | 25.17 | 0.03 | +0.14% |
| iShares iBonds Dec 2029 Term Muni Bond ETF (IBMR) | |||
| HFGM | 29.29 | -0.02 | -0.07% |
| Unlimited Hfgm Global Macro ETF | |||